Showing results (51-60 of 921) with videos related to
Sort By:
Pageof 93
Journal of Neuroimmunology|December 1, 1982
Lymphocytotoxic and monocytotoxic antibodies in the serum and cerebrospinal fluid of multiple sclerosis patientsL Rumbach, M M Tongio, J M Warter, et al.Revue Neurologique|April 9, 2011
[Diagnostic norms of RAPID neuropsychological battery tests for subjects aged 60 to 89 years with Alzheimer's disease]G Sylvestre, G Chopard, G Tio, et al.Revue Neurologique|January 1, 1981
[Stupor due to sodium valproate. Immediate arousal after intravenous diazepam (author's transl)]C Marescaux, J M Bonardi, L Rumbach, et al.Revue Neurologique|February 1, 1996
[Unilateral asterixis and focal brain lesions. 12 cases]L Tatu, T Moulin, V Martin, et al.European Journal of Pharmacology|March 31, 1987
Effects of drugs affecting noradrenergic neurotransmission in rats with spontaneous petit mal-like seizuresG Micheletti, J M Warter, C Marescaux, et al.Revue Neurologique|January 1, 1990
[Magnetic resonance imaging after a one-month interval of lesions of multiple sclerosis in 2 populations, one during an acute attack treated with methylprednisolone, the other stable with no treatment]L Rumbach, J L Dietemann, C Tranchant, et al.Pathologie-Biologie|March 1, 1987
[Cytotoxic antibodies in multiple sclerosis]L Rumbach, M M Tongio, S Mayer, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 4, 2003
Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthmaWilliam E BergerTherapeutics and Clinical Risk Management|August 30, 2008
New approaches to managing asthma: a US perspectiveWilliam E BergerExpert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Once-daily olopatadine ophthalmic solution 0.2% in the treatment of allergic conjunctivitis and rhinoconjunctivitisWilliam E BergerPageof 93